Komori
Presentation materials for financial results4884Kringle Pharma,Inc.Pharmaceuticals

Notice of Earnings Briefing and Live Streaming (Zoom Webinar)

The company announced that it will hold an earnings briefing for the second quarter of the fiscal year ending September 2026 via Zoom Webinar on 14 May, with advance registration and questions accepted. The earnings release is scheduled for 11 May at 15:40.

Worth reading
35Immaterial
Scored from 1 of 6 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Contents of this document

Second quarter of the fiscal year ending September 20261 item taken from the company’s own explanation
What the company explained in this material
New initiatives
Holding an earnings briefing, live streaming via Zoom Webinar, and accepting questions in advance
Contents of this document
ItemDetails
Fiscal Period CoveredSecond quarter of the fiscal year ending September 2026
New initiativesHolding an earnings briefing, live streaming via Zoom Webinar, and accepting questions in advance
Items this document does not state (29)
Document typeNet SalesOperating profitOrdinary incomeNet incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesResults for the three months of the current quarterFull-year earnings forecastProgress against full-year forecastSelf-assessment against the planSegment resultsBreakdown of Factors Affecting the ChangeKey KPIsUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To hold a briefing on the second-quarter results for the fiscal year ending September 2026 and invite investors and analysts to attend.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Earnings Briefing and Live Streaming (Zoom Webinar) | Kringle Pharma,Inc. (4884) timely disclosure | Komori